Subramanian Sankar - 15 Sep 2022 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
Senior VP, Product Development
Signature
/s/ Matthew B. Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
15 Sep 2022
Net transactions value
+$163,198
Form type
4
Filing time
19 Sep 2022, 17:50:15 UTC
Previous filing
25 Feb 2022
Next filing
28 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $87,752 +40,000 $2.19 40,000 15 Sep 2022 Direct F1
transaction NAUT Common Stock Purchase $75,446 +35,000 +88% $2.16 75,000 16 Sep 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 40,000 shares purchased in the price range of $2.145 to $2.2292 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average share price of an aggregate total of 35,000 shares purchased in the price range of $2.10 to $2.21 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.